First-time generic approvals

A discussion of generic drugs recently approved by FDA

Key Points

Ranitidine oral solution, 15 mg/mL (equiv to Zantac syrup)
ACTAVIS

Didanosine for oral solution, 10 mg/mL (equiv to Videx Pediatric Powder for oral solution)
AUROBINDO

Moexipril/hydrochlorothiazide tablets, 12.5/7.5 mg, 25/15 mg, and 12.5/15 mg (equiv to Uniretic tablets)
TEVA